Equinor ASA (EQNR)

Total Costs & Expenses

$80.63B

TTM · Period ending: · USD

EQNR logo

EQNR Total Costs & Expenses

Latest reported$80.63B
EQNR TTM Total Costs & Expenses ($15.84B → $80.63B)
High-resolution chart · PNG

EQNR total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Equinor ASA Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
80,628,053,796
78,377,053,796
79,875,053,796
78,466,000,000
76,230,000,000
74,627,000,000
71,575,000,000
73,870,000,000
73,830,000,000
71,843,000,000
71,079,000,000
68,242,000,000
66,393,000,000
69,228,000,000
70,192,000,000
71,481,000,000
68,403,000,000
61,830,000,000
55,080,000,000
49,397,000,000
49,122,000,000
45,076,000,000
49,174,000,000
49,694,000,000
49,707,000,000
55,231,000,000
51,969,000,000
54,241,000,000
55,498,000,000
56,453,000,000
59,623,000,000
57,548,000,000
54,692,000,000
51,868,000,000
48,294,000,000
46,973,000,000
46,605,000,000
45,503,000,000
43,209,000,000
43,155,442,453
44,171,437,027
45,431,025,178
54,519,607,727
60,807,199,434
68,690,949,677
74,912,624,861
76,526,112,878
75,132,785,437
75,475,848,009
76,136,936,732
77,524,229,883
80,741,228,549
82,115,735,418
86,661,126,832
89,662,168,334
88,185,045,271
88,229,344,378
85,002,393,739
78,931,746,654
76,963,900,239
71,932,941,462
67,638,888,636
64,625,184,436
63,246,182,668
62,727,412,563
59,552,564,623
55,965,623,515
47,545,889,376
52,719,004,893
61,360,112,826
70,742,000,000
89,233,000,000
83,419,000,000
76,276,000,000
68,049,000,000
56,535,000,000
52,458,000,000
50,641,000,000
49,930,000,000
46,810,000,000
47,502,000,000
46,124,000,000
44,170,000,000
47,164,000,000
44,710,000,000
42,047,000,000
39,491,000,000
34,636,000,000
31,893,000,000
29,804,000,000
29,686,000,000
29,734,000,000
29,283,000,000
30,138,000,000
27,933,000,000
24,493,000,000
23,245,000,000
20,913,000,000
15,837,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.